Is it possible to bridge the gap between where your business is today and the world-changing vision in your head without lying? Every entrepreneur faces the temptation of the fake it till you make it strategy, a practice that encourages founders to project more progress than they've actually achieved to secure vital funding and talent. While some see it as harmless optimism, John Carreyrou’s Bad Blood illustrates how this mindset can spiral into a multi-billion dollar disaster.

Elizabeth Holmes founded Theranos with a noble goal of making blood testing painless and accessible. She pitched a future where a single drop of blood from a fingertip could run hundreds of tests. It's a classic example of an entrepreneurial mindset that prioritizes the "big vision" over current technical limitations.

Defining the Concept in Silicon Valley

In the world of Bad Blood, the term describes the practice of promising features or capabilities that don't exist yet but are expected to be built soon. In Silicon Valley culture, this is often treated as a standard operating procedure. Founders like Larry Ellison, an early Theranos investor, famously shipped buggy software at Oracle, believing the engineers would fix the issues before anyone noticed. Carreyrou highlights that this becomes dangerous when applied to healthcare, where a "bug" isn't a software crash, but a life-threatening medical error.

Maintaining Startup Ethics While Scaling

One of the most difficult challenges for a founder is maintaining startup ethics when the pressure to perform for investors mounts. At Theranos, the "fake it" part of the strategy involved deceptive demos for potential partners like Novartis. When Holmes flew to Switzerland, her team knew the devices weren't reliable. To ensure the demo was "perfect," they beamed fake results from California to the readers in Basel.

According to data from the Bureau of Labor Statistics, roughly 20% of new businesses fail within their first two years. This high failure rate often drives founders to cross the line from aspirational marketing into outright fraud. Holmes didn't just sell a vision; she sold recorded results as if they were happening in real time. This behavior isn't just aggressive business—it's a fundamental breach of trust with the people funding the company.

Risks of the Fake It Till You Make It Mindset

When you rely too heavily on the fake it till you make it mindset, you create a culture of compartmentalization. At Theranos, departments weren't allowed to talk to one another, preventing anyone from seeing the full picture of the technology's failure. This secrecy was sold as a way to protect trade secrets, but its actual purpose was to hide the fact that the "revolutionary" technology was actually a converted glue-dispensing robot called the Edison.

This lack of transparency led to a massive talent drain. Carreyrou notes that top executives like the CFO, Henry Mosley, were fired the moment they pointed out that the company was fooling investors. When a startup's culture punishes honesty, it's a sign the "faking it" stage has become permanent.

Deceptions and Real Results

Theranos provides the ultimate cautionary tale of what happens when a bluff is never called. During investor visits, the company's co-founder, Shaunak Roy, would prick his finger and put blood into a cartridge. The investors saw the blood flow on a screen and then saw a result. They didn't know the result was a pre-recorded file from a previous test that had actually worked.

Another example involved the company's expansion into Walgreens and Safeway. Even though the miniLab wasn't ready, Holmes insisted on launching. To hide the technology's flaws, the lab secretly diluted finger-stick samples and ran them on traditional Siemens analyzers. This didn't just deceive partners; it potentially harmed patients by producing inaccurate potassium and sodium levels that could have led to unnecessary medical emergencies.

How to Build Credibility Without Deception

If you want to scale a business without falling into the trap of vaporware, follow these three steps to align your vision with reality.

  1. Use the "Proof of Concept" Label. Be transparent about what is a prototype and what is a finished product. If you're showing a demo, state clearly that it's a simulated environment or a specific use-case rather than a finished, universal solution.
  2. Establish Internal Truth Channels. Allow your engineers and product teams to speak directly to leadership about roadblocks. If your team is afraid to tell you the product doesn't work, you'll continue to sell a lie that you can't eventually fulfill.
  3. Validate with Third Parties. Before taking your product to the mass market, have an independent expert or a small group of beta testers vet your results. This creates a buffer of objective evidence that protects you from the echo chamber of your own optimism.

What the Critics Get Right

Some argue that Silicon Valley culture necessitates a certain amount of bluffing to get anything new off the ground. They suggest that without the initial hype, world-changing companies like Tesla or SpaceX might have run out of money before their technology caught up to the vision. Critics of this view, however, point out that there is a massive difference between a delayed shipping date and a fraudulent product.

In the medical and financial sectors, the margin for error is zero. Experts in laboratory science argue that Holmes’s greatest sin wasn't her ambition, but her refusal to accept the laws of physics. You can't fit the functionality of a massive lab into a tiny box if the science doesn't support it. Relying on an entrepreneurial mindset to ignore physical realities isn't visionary—it's reckless.

This concept is about the dangerous gap between who you are and who you want to be. While a certain level of confidence helps you secure funding, hiding technical failure with fake data is a crime. Real growth requires your technology to eventually catch up to your marketing. Audit your current product claims against your actual capabilities this week to ensure you aren't crossing into deception.

Questions

How does Silicon Valley culture influence the fake it till you make it mindset?

Silicon Valley culture often rewards 'moonshot' thinking and extreme confidence. VCs and investors are frequently looking for the next big disruption, which creates immense pressure for founders to project more progress than they have. This environment can encourage bluffing, as founders feel they must maintain a facade of success to keep funding rounds open and attract top-tier talent in a competitive market.

What is the difference between a vision and vaporware?

A vision is a future goal backed by ongoing, honest research and development efforts. Vaporware occurs when a company markets a product that does not exist and has no clear path to existing. In the case of Theranos, the 'vision' became 'vaporware' when the company began using deceptive demos and faked data to hide the fact that the actual science behind the product was failing.

Can the entrepreneurial mindset lead to ethical breaches?

Yes, if an entrepreneurial mindset isn't balanced with strong internal controls and ethics, it can lead to disaster. Entrepreneurs are naturally optimistic, which can sometimes lead them to downplay risks or ignore technical failures. When this optimism turns into a refusal to acknowledge the truth—especially in high-stakes fields like healthcare or finance—it often results in major ethical and legal violations.

How can a startup maintain ethics during rapid growth?

Maintaining startup ethics requires transparency and a culture where employees feel safe reporting failures. Leadership must prioritize 'ground truth' over optics. This means setting realistic milestones, being honest with investors about technical hurdles, and ensuring that marketing claims never outpace the actual capabilities of the product. Implementing external audits and third-party validation also helps keep a growing company grounded in reality.